Preventable medication harm across health care settings: a systematic review and meta-analysis

BMC Medicine
http://www.biomedcentral.com/bmcmed/content
(Accessed 7 Nov 2020)

 

Preventable medication harm across health care settings: a systematic review and meta-analysis
Mitigating or reducing the risk of medication harm is a global policy priority. But evidence reflecting preventable medication harm in medical care and the factors that derive this harm remain unknown. Therefore, we aimed to quantify the prevalence, severity and type of preventable medication harm across medical care settings.,, This is the largest meta-analysis to assess preventable medication harm. We conclude that around one in 30 patients are exposed to preventable medication harm in medical care, and more than a quarter of this harm is considered severe or life-threatening. Our results support the World Health Organisation’s push for the detection and mitigation of medication-related harm as being a top priority, whilst highlighting other key potential targets for remedial intervention that should be a priority focus for future research.
Authors: Alexander Hodkinson, Natasha Tyler, Darren M. Ashcroft, Richard N. Keers, Kanza Khan, Denham Phipps, Aseel Abuzour, Peter Bower, Anthony Avery, Stephen Campbell and Maria Panagioti
Citation: BMC Medicine 2020 18:313
Content type: Research article
Published on: 6 November 2020